Aurinia Pharmaceuticals Inc. (FRA:IKAP)

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had revenue of $73.47M USD in the quarter ending September 30, 2025, with 8.41% growth. This brings the company's revenue in the last twelve months to $265.81M, up 20.62% year-over-year. In the year 2024, Aurinia Pharmaceuticals had annual revenue of $235.13M with 33.97% growth.

• Revenue (ttm): $265.81M
• Revenue Growth: +20.62%
• P/S Ratio: 8.09
• Revenue / Employee: $2.04M
• Employees: 130
• Market Cap: 1.83B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	235.13M	59.62M	33.97%
Dec 31, 2023	175.51M	41.48M	30.95%
Dec 31, 2022	134.03M	88.43M	193.89%
Dec 31, 2021	45.61M	-4.51M	-9.00%
Dec 31, 2020	50.12M	49.80M	15,660.38%
Dec 31, 2019	318.00K	-145.00K	-31.32%
Dec 31, 2018	463.00K	45.00K	10.77%
Dec 31, 2017	418.00K	245.00K	141.62%
Dec 31, 2016	173.00K	-	-